PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
159 hedge funds and large institutions have $612M invested in Progenics Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
159
Holders Change
+33
Holders Change %
+26.19%
% of All Funds
3.96%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
56
Increased
45
Reduced
36
Closed
16
Calls
$6.1M
Puts
$3.62M
Net Calls
+$2.48M
Net Calls Change
+$1.34M
Top Buyers
| 1 |
1
BlackRock
New York
|
$89.9M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$39M |
| 3 |
PWAM
3
Park West Asset Management
San Francisco,
California
|
$23.5M |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$13.4M |
| 5 |
5
Goldman Sachs
New York
|
$7.88M |
Top Sellers
| 1 |
BC
1
Broadfin Capital
New York
|
$18.9M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$28.2M |
| 3 |
3
AllianceBernstein
Nashville,
Tennessee
|
$2.27M |
| 4 |
RA
4
Royce & Associates
New York
|
$11.8M |
| 5 |
PFC
5
Phocas Financial Corp
Alameda,
California
|
$13.2M |
